OTCMKTS:ORINY ORION OYJ/ADR Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ORION OYJ/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $25.05 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$25.05Now: $25.05▼$25.0550-Day Range$25.05MA: $25.05▼$25.0552-Week Range$18.65Now: $25.05▼$27.00VolumeN/AAverage Volume840 shsMarket Capitalization$7.08 billionP/E Ratio24.56Dividend Yield2.08%Beta0.64 ProfileChartCompetitorsDividendEarningsHeadlinesShort InterestSocial Media Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs. This segment provides proprietary drugs in the areas of central nervous system, oncology and critical care, and pulmonary care; generic prescription drugs, as well as self-care products, such as non-prescription medicines, basic ointments, and vitamins; proprietary and generic veterinary drugs; and APIs for generic and proprietary drugs, as well as offers contract manufacturing services for APIs. This segment also markets and sells veterinary drugs manufactured by other international companies. The Diagnostics segment develops, manufactures, and markets in vitro diagnostic test systems and tests for diagnosing diseases and monitoring treatment efficacy. Orion Oyj has a strategic alliance with Novan, Inc. to manufacture topical nitric oxide-releasing product candidates; and research collaboration with Fifth Corner Inc. to seek solutions to improve the quality of life of prostate cancer patients. The company was founded in 1917 and is headquartered in Espoo, Finland.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ORION OYJ/ADR. Previous Next 2.1 Community Rank Outperform VotesORION OYJ/ADR has received 95 “outperform” votes. (Add your “outperform” vote.)Underperform VotesORION OYJ/ADR has received 132 “underperform” votes. (Add your “underperform” vote.)Community SentimentORION OYJ/ADR has received 58.15% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ORION OYJ/ADR and other stocks. Vote “Outperform” if you believe ORINY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ORINY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend YieldORION OYJ/ADR pays a meaningful dividend of 2.08%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthORION OYJ/ADR does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of ORION OYJ/ADR is 65.00%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, ORION OYJ/ADR will have a dividend payout ratio of 66.67% next year. This indicates that ORION OYJ/ADR will be able to sustain or increase its dividend. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ORION OYJ/ADR insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ORION OYJ/ADR are expected to decrease by -4.88% in the coming year, from $0.82 to $0.78 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ORION OYJ/ADR is 24.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.81.Price to Earnings Ratio vs. SectorThe P/E ratio of ORION OYJ/ADR is 24.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.18.Price to Book Value per Share RatioORION OYJ/ADR has a P/B Ratio of 8.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.05 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ORINY Previous SymbolNASDAQ:ORINY CUSIPN/A CIKN/A Webwww.orion.fi Phone358 10 4261Debt Debt-to-Equity Ratio0.15 Current Ratio2.98 Quick Ratio1.88Price-To-Earnings Trailing P/E Ratio24.56 Forward P/E Ratio30.55 P/E GrowthN/A Sales & Book Value Annual Sales$1.18 billion Price / Sales6.01 Cash Flow$1.08 per share Price / Cash Flow23.25 Book Value$3.10 per share Price / Book8.08Profitability EPS (Most Recent Fiscal Year)$0.80 Net Income$224.45 million Net Margins22.98% Return on Equity34.03% Return on Assets24.00%Miscellaneous Employees3,179 Outstanding Shares282,520,000Market Cap$7.08 billion Next Earnings Date10/28/2020 (Estimated) OptionableNot Optionable $25.05 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ORINY News and Ratings via Email Sign-up to receive the latest news and ratings for ORINY and its competitors with MarketBeat's FREE daily newsletter. ORION OYJ/ADR (OTCMKTS:ORINY) Frequently Asked Questions How has ORION OYJ/ADR's stock price been impacted by Coronavirus (COVID-19)? ORION OYJ/ADR's stock was trading at $20.78 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ORINY shares have increased by 20.5% and is now trading at $25.05. View which stocks have been most impacted by COVID-19. When is ORION OYJ/ADR's next earnings date? ORION OYJ/ADR is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020. View our earnings forecast for ORION OYJ/ADR. How were ORION OYJ/ADR's earnings last quarter? ORION OYJ/ADR (OTCMKTS:ORINY) announced its earnings results on Friday, July, 17th. The company reported $0.30 earnings per share (EPS) for the quarter. The firm had revenue of $322.01 million for the quarter. ORION OYJ/ADR had a net margin of 22.98% and a return on equity of 34.03%. View ORION OYJ/ADR's earnings history. Who are some of ORION OYJ/ADR's key competitors? Some companies that are related to ORION OYJ/ADR include SEVEN & I HOLDI/ADR (SVNDY), Fujitsu (FJTSY), Eisai (ESALY), AMADEUS IT HLDG/ADR (AMADY), SANDVIK AB/ADR (SDVKY), UNICHARM CORP/S (UNICY), OCADO GRP PLC/S (OCDDY), HENNES & MAURIT/ADR (HNNMY), ASSA ABLOY AB/S (ASAZY), PADDY PWR BETFA/ADR (PDYPY), CK HUTCHISON HO/ADR (CKHUY), KERRY GRP PLC/S (KRYAY), Techtronic Industries (TTNDY), SAMPO OYJ/ADR (SAXPY) and ZALANDO SE/ADR (ZLNDY). View all competitors. Who are ORION OYJ/ADR's key executives? ORION OYJ/ADR's management team includes the following people: Mr. Timo Lappalainen, CEO, Pres & Chairman of the Exec. Management Board (Age 57)Mr. Jari Karlson M.Sc. (Econ.), CFO, Sr. VP of Animal Health & Member of the Exec. Management Board (Age 58)Mr. Olli Huotari, Sr. VP of Corp. Functions, Gen. Counsel, Sec. & Member of Exec. Management Board (Age 53)Mr. Markku Huhta-Koivisto, Sr. VP of Growth Projects & Member of Exec. Management Board (Age 63)Ms. Satu Ahomäki, Sr. VP of Commercial Operations and Member of the Exec. Management Board (Age 53) What is ORION OYJ/ADR's stock symbol? ORION OYJ/ADR trades on the OTCMKTS under the ticker symbol "ORINY." How do I buy shares of ORION OYJ/ADR? Shares of ORINY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ORION OYJ/ADR's stock price today? One share of ORINY stock can currently be purchased for approximately $25.05. How big of a company is ORION OYJ/ADR? ORION OYJ/ADR has a market capitalization of $7.08 billion and generates $1.18 billion in revenue each year. The company earns $224.45 million in net income (profit) each year or $0.80 on an earnings per share basis. ORION OYJ/ADR employs 3,179 workers across the globe. What is ORION OYJ/ADR's official website? The official website for ORION OYJ/ADR is www.orion.fi. How can I contact ORION OYJ/ADR? ORION OYJ/ADR's mailing address is Orionintie 1A, Espoo H9, 02200. The company can be reached via phone at 358 10 4261 or via email at [email protected] This page was last updated on 9/20/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
